AlorAir Showcases Comprehensive Clean Air Solutions at ISSA Show North America 2025

Las Vegas, Nov. 17, 2025 (GLOBE NEWSWIRE) — From November 10-13, AlorAir, a leading manufacturer of restoration and indoor air quality solutions, exhibited at the ISSA Show North America 2025, held at the Mandalay Bay Convention Center in Las Vegas, Nevada. The company showcased its lineup of high-efficiency air scrubbers, dust collectors, and filtration systems, […]

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

(NasdaqGM:EYPT), WATERTOWN, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company's 2023 Long-Term Incentive Plan

Validic Joins Digital Medicine Society Initiative to Advance Connected Health for Older Adults

DURHAM, N.C., Nov. 17, 2025 (GLOBE NEWSWIRE) — When Drew Schiller, CEO of Validic, thinks about why connected health matters, he thinks of his grandmother, Betty. Betty was the center of her family: kind, generous, and devoted to caring for others. Later in life, she developed COPD and other chronic conditions that required close management.

Sharps Technology Reports Strong Growth in Q3 2025 as it Advances Execution of Treasury Strategy

(NASDAQ:STSS),(NASDAQ:STSSW), NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (“STSS” or the “Company”), a U.S.-based medical device sales and distribution platform that has adopted a Solana-based treasury strategy, today announced financial results for the third quarter ended September 30, 2025, and provided updates on the execution of its capital markets and digital

The Vita Coco Company Issues Statement Regarding Tariff Relief

(NASDAQ:COCO), NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) — The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), a leading high-growth platform of better-for-you beverage brands, today provided the following response to the recent Executive Order modifying the scope of the reciprocal tariff with respect to certain agricultural products. On Friday, November

Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update

(TSX-V:LOVE),(OTC US:LOVFF),(Other OTC:LOVFF),(Boerse Frankfurt – Freiverkehr:8CB0.F), MONTREAL, Nov. 17, 2025 (GLOBE NEWSWIRE) — Cannara Biotech Inc. (“Cannara“, “the Company“, “us” or “we“) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at disruptive prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that it

Mobix Labs Takes Action Against Denis Tse, ACE Equity Partners International, Asia-IO, and ACE SO4 to Recover Over $250 Million in Damages

(NASDAQ:MOBX), IRVINE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) — Mobix Labs, Inc. (NASDAQ: MOBX) (“Mobix”), a fast-growing semiconductor and defense-technology company, announced today that it has filed a Verified Complaint in the Delaware Court of Chancery alleging that Tik Yang Tse (also known as Denis Tse), ACE Equity Partners International, Asia-IO Equity Partners International, and

Brady Corporation Reports Fiscal 2026 First Quarter Results and Raises the Low End of its Fiscal 2026 Adjusted Diluted EPS Guidance

(NYSE:BRC), Sales for the quarter increased 7.5 percent. Organic sales increased 2.8 percent, acquisitions increased sales 3.2 percent, and foreign currency increased sales 1.5 percent. Diluted EPS increased 16.5 percent to $1.13 in the first quarter of fiscal 2026 compared to $0.97 in the same quarter of the prior year. Adjusted Diluted EPS* increased 8.0

Abaxx Provides Q3 2025 Corporate Update

(Neo:ABXX.NE),(OTC US:ABXXF),(Other OTC:ABXXF), TORONTO, Nov. 17, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company“), a financial software and market infrastructure company, indirect majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore“), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing“), and producer of the SmarterMarkets(TM) Podcast,

Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement

(CNSX:AGN.CN),(OTC US:AGNPF),(Other OTC:AGNPF),(CNSX:AGN),(Boerse Frankfurt – Freiverkehr:AGW0.F), NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 17, 2025 (GLOBE NEWSWIRE) — Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, and American Molecular Imaging (AMI), one of the leading

Scroll to Top